⚠️ High Alert Medication

Isoprenaline (Isoproterenol) Infusion

Syringe pump continuous infusion preparation (20 mcg/mL), chronotropic titration, and arrhythmia surveillance protocol.

Syringe Pump Infusion Preparation (Standard Concentration)

Ampoule Presentation 5 mL ampoule (0.2 mg/mL = 200 mcg/mL of isoprenaline hydrochloride)
Isoprenaline Dose 1 mg (5 mL = one 5 mL ampoule)
Compatible Diluent 45 mL of 5% Dextrose (D5W)
Final Syringe Volume 50 mL
Final Concentration 20 mcg/mL
Stability 24 hours at room temperature, protected from light

Materials Required

  • Isoprenaline ampoule 0.2 mg/mL (5 mL) × 1
  • 60 mL Luer-lock syringe
  • 5% Dextrose (D5W)
  • Sterile drawing-up needle / filter needle
  • Dedicated syringe pump infusion label
  • Extension line (100 cm), light-protective if available
  • Alcohol chlorhexidine swabs
⚠️ Strength Check: Isoprenaline ampoules are supplied in different strengths by different manufacturers (for example 0.2 mg/mL and 1 mg/mL). Always confirm the ampoule strength and recalculate the volume needed for 1 mg before drawing up.

Preparation Procedure (Aseptic Non-Touch Technique)

  1. Verification: Verify the written physician order, patient identity, clinical indication, baseline heart rate, rhythm, and QT interval.
  2. Hand Hygiene: Perform thorough hand hygiene and clean preparation workspace.
  3. Ampoule Check: Check the isoprenaline ampoule for:
    • Correct drug and strength (mg/mL), isoprenaline hydrochloride
    • Expiry date
    • Container integrity, clarity, and absence of precipitate or discoloration
  4. Withdrawal: Withdraw 5 mL from one 0.2 mg/mL ampoule into a 60 mL Luer-lock syringe (Total isoprenaline drawn: 5 mL = 1 mg isoprenaline).
  5. Dilution: Add 45 mL of 5% Dextrose to a final volume of 50 mL.
  6. Mixing: Gently invert the syringe several times to ensure uniform mixing.
  7. Visual Inspection: Inspect solution to ensure it is clear, colorless, and free of visible particles. A pink or brown tint indicates oxidation; discard the syringe.
  8. Labeling & Dual Verification: Apply infusion label and obtain an independent double-check by another registered nurse.
  9. Syringe Pump Setup: Prime the extension set, install into the syringe pump, and protect from light.

🔒 Lumen Policy: Isoprenaline is inactivated in alkaline solutions (sodium bicarbonate). Infuse via a dedicated lumen so flushes of other drugs do not deliver an unintended bolus.

⚠️ Line Access: Isoprenaline may be infused via a peripheral or central line. It is a bridge therapy: arrange temporary or permanent pacing early when bradycardia is caused by heart block.

Receptor & Hemodynamic Profile

Isoprenaline is a pure, non-selective β-agonist with virtually no α-activity. Heart rate and contractility rise, while systemic vascular resistance falls.

β1 Stimulation (Cardiac)

↑ Heart Rate & AV Conduction
  • Increases sinus rate, escape rhythms, and AV nodal conduction
  • Increases contractility and cardiac output

β2 Stimulation (Vascular)

↓ SVR & Diastolic Pressure
  • Peripheral vasodilation; mean arterial pressure may fall
  • Bronchodilation

Net Myocardial Effect

↑↑ Oxygen Demand
  • Tachycardia with lower diastolic (coronary perfusion) pressure
  • High risk of ischemia in coronary artery disease

Administration & Titration

Recommended Dosing Parameters

  • Dosing Unit: Usually dosed in mcg/min (weight-based equivalent 0.01 to 0.1 mcg/kg/min).
  • Administration Route: Administer via syringe pump; dedicated lumen preferred.
  • Recommended Starting Dose: 0.5 to 1 mcg/min.
  • Titration Step: Increase by 0.5 to 1 mcg/min every 3 to 5 minutes to the prescribed heart rate target.
  • Typical Range: 0.5 to 5 mcg/min.
  • Higher Doses: Up to 10 mcg/min only under direct intensivist or cardiology supervision.
  • Heart Rate Target: The lowest rate that restores adequate perfusion, as prescribed (for example 60–80 bpm, or higher for torsades suppression).
  • Syringe Continuity: Do not allow the infusion to run out. A syringe can be made up to a maximum of 1 hour in advance and labelled clearly with contents and expiry.
  • Discard Policy: Discard 24 hours after preparation or earlier if the solution becomes discoloured, cloudy, or contaminated.

Hemodynamic Monitoring Requirements

  • Continuous ECG monitoring with transcutaneous pacing pads applied and pacing equipment at the bedside.
  • Monitor heart rate continuously and blood pressure every 5 minutes during titration (arterial line preferred).
  • Watch for ventricular ectopy, ventricular tachycardia, and atrial tachyarrhythmias.
  • Observe for chest pain or ECG changes suggesting myocardial ischemia.
  • Check serum potassium and magnesium; β-agonism lowers potassium and hypokalemia increases arrhythmia risk.
  • Monitor blood glucose; isoprenaline may cause hyperglycemia.

Indications & Cautions

  • Uses: Symptomatic bradycardia or complete heart block unresponsive to atropine (bridge to pacing); bradycardia-dependent torsades de pointes with acquired long QT.
  • Congenital Long QT: Contraindicated; adrenergic stimulation can trigger torsades.
  • Ischemic Heart Disease: Avoid or use with extreme caution because of increased oxygen demand.
  • Existing Tachyarrhythmias or Digitalis Toxicity: Contraindicated.

Arrhythmia & Ischemia Response Protocol

Isoprenaline is not a vesicant; its principal hazards are tachyarrhythmias, myocardial ischemia, and hypotension. Its short half-life means effects fade within minutes of stopping.

Expected Response

  • Heart rate at prescribed target
  • Blood pressure and perfusion maintained
  • No chest pain or new ST changes
  • No new ventricular ectopy

Tachyarrhythmia, Chest Pain, or Hypotension:

  1. STOP or reduce infusion immediately.
  2. Notify clinician promptly; obtain a 12-lead ECG.
  3. Prepare for pacing if bradycardia recurs after stopping.
  4. Check potassium and magnesium.
  5. Document event in patient clinical record.

Isoprenaline Infusion Rate Chart (20 mcg/mL)

Shows the pump rate (mL/hr) for each dose in mcg/min, with the equivalent weight-based dose in mcg/kg/min for reference.

Dose
(mcg/min)
Pump Rate
(mL/hr)
Equivalent Dose (mcg/kg/min)
50 kg 70 kg 90 kg
0.51.50.0100.0070.006
130.0200.0140.011
1.54.50.0300.0210.017
260.0400.0290.022
2.57.50.0500.0360.028
390.0600.0430.033
4120.0800.0570.044
5150.1000.0710.056
6180.1200.0860.067
8240.1600.1140.089
10300.2000.1430.111
Typical range (0.5–5 mcg/min) Above typical range: specialist supervision

Infusion Conversion (Solution Concentration 20 mcg/mL)

Standard equations for a 20 mcg/mL solution (1 mg in 50 mL):

Infusion Rate (mL/hr):

Rate (mL/hr) = [ Dose (mcg/min) × 60 ] / 20

Shortcut: Rate = Dose × 3
Infusion Dose (micrograms/minute):

Dose (mcg/min) = [ Rate (mL/hour) × Concentration (20 mcg/mL) ] / 60

Shortcut: Dose = Rate ÷ 3

'Shortcut' example: 2 mcg/min → 2 × 3 = 6 mL/hr.

© criticalcareinsights.com. All rights reserved. For clinical reference and educational use only.